|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent HEB insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why HEB insider buys are important for investors to follow.
Date | Insider | Price | Amount |
6-27-2019 Insider Buy |
Thomas K. Equels Exec. Vice Chairman/CEO/Pres. |
$4.37
CAGR »
|
$11,501.84 2,632 shares |
6-21-2019 Insider Buy |
Thomas K. Equels Exec. Vice Chairman/CEO/Pres. |
$4.03
CAGR »
|
$118,498.12 29,404 shares |
6-21-2019 Insider Buy |
David R. Strayer Chief Science/Medical Officer |
$4.03
CAGR »
|
$9,998.43 2,481 shares |
6-21-2019 Insider Buy |
Peter W. Rodino III Dir Govt Relations/Sectry |
$4.03
CAGR »
|
$35,040.85 8,695 shares |
6-21-2019 Insider Buy |
Stewart Appelrouth Director |
$4.03
CAGR »
|
$38,998.31 9,677 shares |
6-21-2019 Insider Buy |
Wayne S. Springate Sr. VP of Operations |
$4.03
CAGR »
|
$21,000.33 5,211 shares |
6-21-2019 Insider Buy |
William M. Mitchell Director |
$4.03
CAGR »
|
$38,998.31 9,677 shares |
11-30-2018 Insider Buy |
Thomas K. Equels Exec. Vice Chairman/CEO/Pres. |
$0.19
CAGR »
|
$3,844.99 20,000 shares |
11-5-2018 Insider Buy |
Stewart Appelrouth Director |
$0.22
CAGR »
|
$5,552.36 25,238 shares |
10-26-2018 Insider Buy |
Thomas K. Equels Exec. Vice Chairman/CEO/Pres. |
$0.20
CAGR »
|
$710.50 3,500 shares |
10-25-2018 Insider Buy |
Thomas K. Equels Exec. Vice Chairman/CEO/Pres. |
$0.20
CAGR »
|
$20,000.00 100,000 shares |
7-27-2018 Insider Buy |
Thomas K. Equels Exec. Vice Chairman/CEO/Pres. |
$0.29
CAGR »
|
$10,000.07 34,483 shares |
7-24-2018 Insider Buy |
Stewart Appelrouth Director |
$0.31
CAGR »
|
$39,060.00 126,000 shares |
7-23-2018 Insider Buy |
Thomas K. Equels Exec. Vice Chairman/CEO/Pres. |
$0.31
CAGR »
|
$35,000.24 112,904 shares |
7-23-2018 Insider Buy |
Wayne S. Springate Sr. VP of Operations |
$0.31
CAGR »
|
$10,000.29 32,259 shares |
7-23-2018 Insider Buy |
Adam Pascale CFO |
$0.31
CAGR »
|
$10,000.29 32,259 shares |
4-27-2018 Insider Buy |
Thomas K. Equels CEO, President |
$0.32
CAGR »
|
$10,240.00 32,000 shares |
4-27-2018 Insider Buy |
Stewart Appelrouth Director |
$0.32
CAGR »
|
$32,000.00 100,000 shares |
5-2-2017 Insider Buy |
David R. Strayer Chief Science/Medical Officer |
$0.63
CAGR »
|
$5,000.31 7,937 shares |
2-16-2017 Insider Buy |
David R. Strayer Chief Science/Medical Officer |
$0.46
CAGR »
|
$4,550.32 9,892 shares |
12-22-2016 Insider Buy |
Thomas K. Equels CEO, President |
$0.73
CAGR »
|
$49,999.89 68,493 shares |
11-1-2016 Insider Buy |
Thomas K. Equels CEO,President |
$1.00
CAGR »
|
$10,000.00 10,000 shares |
7-8-2016 Insider Buy |
Thomas K. Equels CEO, President |
$0.12
CAGR »
|
$5,683.20 48,000 shares |
7-1-2016 Insider Buy |
Thomas K. Equels CEO,President |
$0.12
CAGR »
|
$20,424.30 171,000 shares |
3-18-2016 Insider Buy |
Thomas K. Equels CEO,Pres,Exec Vice Chairman |
$0.13
CAGR »
|
$3,966.00 30,000 shares |
3-11-2016 Insider Buy |
Thomas K. Equels CEO,Pres,Exec Vice Chairman |
$0.16
CAGR »
|
$6,310.00 40,000 shares |
3-10-2016 Insider Buy |
Thomas K. Equels CEO,Pres,Exec Vice Chairman |
$0.16
CAGR »
|
$4,890.00 30,000 shares |
8-20-2015 Insider Buy |
William A. Carter CEO |
$0.18
CAGR »
|
$4,487.50 25,000 shares |
8-18-2015 Insider Buy |
William A. Carter CEO |
$0.18
CAGR »
|
$4,550.00 25,000 shares |
8-17-2015 Insider Buy |
William A. Carter CEO |
$0.18
CAGR »
|
$4,537.50 25,000 shares |
8-14-2015 Insider Buy |
Thomas K. Equels CFO, Pres.,Sec., Vice Chairman |
$0.18
CAGR »
|
$14,240.42 79,104 shares |
4-28-2015 Insider Buy |
William A. Carter CEO |
$0.24
CAGR »
|
$24,200.00 100,000 shares |
4-27-2015 Insider Buy |
Thomas K. Equels CFO, Vice Chairman, Secretary |
$0.24
CAGR »
|
$24,430.00 100,000 shares |
4-21-2015 Insider Buy |
William A. Carter CEO |
$0.24
CAGR »
|
$24,000.00 100,000 shares |
4-20-2015 Insider Buy |
Thomas K. Equels CFO, Vice Chairman, Secretary |
$0.24
CAGR »
|
$23,910.00 100,000 shares |
4-17-2015 Insider Buy |
William A. Carter CEO |
$0.23
CAGR »
|
$16,946.63 73,681 shares |
4-16-2015 Insider Buy |
William A. Carter CEO |
$0.23
CAGR »
|
$6,053.37 26,319 shares |
4-15-2015 Insider Buy |
Thomas K. Equels CFO, Vice Chairman, Secretary |
$0.23
CAGR »
|
$22,540.00 100,000 shares |
5-18-2012 Insider Buy |
David R. Strayer
|
$0.26
CAGR »
|
$12,750.00 50,000 shares |
Also See: Institutional Holders of HEB
Also See: SEC filings
Below we present the annualized performance delivered by HEB stock since 6-27-2019 (the date of the most recent
insider purchase). The performance of the investment from the time HEB insider buying occurred is the ultimate
test of whether insiders were right about HEB being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
06/28/2019 |
|
End date: |
08/30/2019 |
|
Start price/share: |
$4.39 |
|
End price/share: |
$1.80 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-59.00% |
|
Annualized Gain: |
-341.81% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$4,100.00 |
|
Years: |
0.17 |
|
HEB Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent HEB insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding HEB
|
|